🔎 Trials Near Me

Pradžia › Ūmi limfoblastinė leukemija › Oklahoma

Ūmi limfoblastinė leukemija klinikiniai tyrimai Oklahoma

8 tyrimai dėl Ūmi limfoblastinė leukemija ieško dalyvių vietose Oklahoma.

Miestai Oklahoma

Oficialus tyrimo tekstas (anglų kalba)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Hospital Oklahoma City, Oklahoma City
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

  • Board of Regents of the University of Oklahoma Health Sciences Center, Oklahoma City
Renkami dalyviaiStebimasis tyrimas
1 Day – 17 Years · Visoms lytims · Atnaujinta 2026-08-14 · NCT06274788

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

  • Saint Francis Children's Hospital, Tulsa
Renkami dalyviai2 fazė
Amžius nuo 1 iki 18 · Visoms lytims · Atnaujinta 2026-07-16 · NCT06533748

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

  • Saint Francis Children's Hospital, Tulsa
Renkami dalyviai4 fazė
Amžius nuo 1 iki 18 · Visoms lytims · Atnaujinta 2026-07-14 · NCT06289673

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Oklahoma Health Science Center, Oklahoma City
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-07-06 · NCT01351545

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • University of Oklahoma Health Sciences Center, Oklahoma City
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-05-18 · NCT01790152

Pilot Imaging Study of Leukemia

  • University of Oklahoma Health Sciences Center, Oklahoma City
Renkami dalyviai1 fazė
Amžius nuo 4 iki 80 · Visoms lytims · Atnaujinta 2026-04-23 · NCT03633955

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.